Real-time enrollment status for this glaucoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 7:03 PM UTC
| NCT Number | NCT06822738 |
| Recruiting Status | Recruiting |
| Condition | Glaucoma |
| Phase | PHASE3 |
| Target Enrollment | 130 participants |
| Active Locations | 29 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT06822738 is currently recruiting participants. This phase3 study for glaucoma is actively seeking new participants at 29 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06822738 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06822738 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.